HIV infection continues to affect the health and well-being of nearly 2.6 million people in the WHO European Region, particularly in the eastern part of the ...
The data in Table 8 suggest that data cut 9 months after the primary double-blind analysis has shown improvement in mOS and a similar mPFS in the ripretinib arm ...